© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
The addition of bevacizumab (Avastin) to trabeculectomy improves the success rate of IOP control, particularly in young diabetic patients with neovascular glaucoma (NVG), according to a study published online, ahead of print, by Eye.
Related Content: